# Pharmacogenetics of Leflunomide in the Management of Rheumatoid Arthritis

> **NCT07388407** · — · RECRUITING · sponsor: **Foundation University Islamabad** · enrollment: 110 (estimated)

## Conditions studied

- Rhematoid Arthritis

## Interventions

- **DRUG:** Study for the correlation of SNPs with efficacy and toxicity of Leflunomide in RA patients

## Key facts

- **NCT ID:** NCT07388407
- **Lead sponsor:** Foundation University Islamabad
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2026-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07388407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07388407, "Pharmacogenetics of Leflunomide in the Management of Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07388407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*